1. Scrip
  2. >>Business

AC Immune CEO Outlines ‘Roadmap’ For Fighting Alzheimer’s

Andrea Pfeifer Outlines Her Key Points For Future AD Treatment

 
• By Sten Stovall

AC Immune’s CEO tells Scrip that treating earlier, targeting Tau, and focusing on more homogeneous populations will be needed to successfully fight Alzheimer’s Disease.

Dementia_Scans
AC Immune has a broad pipeline of Abeta- and Tau-targeted therapies • Source: Shutterstock

AC Immune SA and its pharmaceutical partners are following a five-point strategy for advancing its pipeline of Abeta- and Tau-targeted therapies in Alzheimer’s Disease, and coming data readouts should offer multiple catalysts for the Swiss biotech’s stock, its CEO told Scrip.

Andrea Pfeifer outlined her five-point “Roadmap” to successful therapies for neurodegenerative diseases that recognizes the importance of treating earlier, targeting...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

In Brief: Kezar Plots Lupus Revival For Zetomipzomib As FDA Lifts Hold On Hepatitis Trial

 
• By Manas Mishra

The go-ahead to resume a trial for its only drug candidate, zetomipzomib, in hepatitis could give Kezar a glimmer of hope of reviving another halted study in lupus nephritis.

In partnership with

Podcast: Strategic Insights into the RNA Market

Discover the latest trends in RNA-based therapeutics and learn how sponsors can successfully navigate the road to next generation innovation. Listen in as Citeline chats with the Director of Therapeutics at Novotech, a CRO experienced in RNA development.

China Sentences Astellas Employee To 3.5 Years In Prison On Spy Charges

 
• By Lisa Takagi

An employee of Astellas faces three and a half years in prison after sentencing by a court in China on espionage charges.